Home › NCT01870752

Ovarian Tissue Transplantation

Autologous Orthotopic Transplantation of Previously Cryopreserved Ovarian Tissue

Who can join

Ages 18 to 45 · Women

Inclusion Criteria:

* Female patient between the ages of 18 and 45 years
* Previously cryopreserved and stored cortical ovarian tissue available for autologous transplantation
* Ovarian insufficiency defined as an elevated FSH over 10
* Inability to conceive after 6 months of unprotected intercourse with male
* Reasonably good health
* Candidate for pregnancy
* Written clearance for the procedure from the patients oncologist

Exclusion Criteria:

* Patients considered to be high risk for surgical complications will be excluded from the research protocol
* Women who are known to be positive for the BRCA mutation
* Women with a history of leukemia, ovarian cancer or a cancer that likely involved the ovaries at the time of ovarian tissue collection
* Women with psychological, psychiatric, or other conditions which prevent giving fully informed consent
* Current pregnancy

About the study

Chemotherapy and radiation therapy for the treatment of cancer can compromise fertility. Ovarian tissue cryopreservation is an experimental strategy offered at The University of Pennsylvania to preserve future fertility (protocol 806062). The primary objective of this study is to determine the efficacy and safety of autologous transplantation of previously cryopreserved ovarian cortical tissue in patients who experience infertility or ovarian insufficiency after cancer treatments.

What is being tested

• Transplantation of previously cryopreserved ovarian tissu (procedure)

Sponsor: Abramson Cancer Center at Penn Medicine · Participants: 10 · Started: 2013-06

Contact the study team

• Clarisa Gracia, MD · Phone: 877-204-9213

Official record on ClinicalTrials.gov — NCT01870752

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.